Resveratrol: A Double-Edged Sword in Health Benefits.

Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J. · 2018

Read Resveratrol: A Double-Edged Sword in Health Benefits. by Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6164842.txt.

Introduction

Salehi and co-authors wrote a review in Biomedicines on resveratrol, a plant polyphenol found in grapes and red wine. It occurs in more than 70 plant species, mostly in grape skin and seeds. Plants make it to fight bacteria and fungi. Studies credit it with strong antioxidant power.

The review sums up evidence for antitumor activity and other health effects. Lab and animal studies support a role in preventing and treating several cancers. Yet the title calls it a double-edged sword. Dose and context can change what it does in the body. The authors weigh the promise against those limits, giving readers both edges of the evidence.

Catalog record

CREATORSalehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE84 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6164842

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Resveratrol: A Double-Edged Sword in Health Benefits By Bahare Salehi, Abhay Prakash Mishra, Manisha Nigam, Bilge Sener, Mehtap Kilic, Mehdi Sharifi-Rad, Patrick Valere Tsouh Fokou, Natália Martins, Javad Sharifi-Rad Published in: Biomedicines DOI: 10.3390/biomedicines6030091 ABSTRACT Abstract Resveratrol (3,5,4′-trihydroxy-trans-stilbene) belongs to polyphenols’ stilbenoids group, possessing two phenol rings linked to each other by an ethylene bridge. This natural polyphenol has been detected in more than 70 plant species, especially in grapes’ skin and seeds, and was found in discrete amounts in red wines and various human foods. It is a phytoalexin that acts against pathogens, including bacteria and fungi. As a natural food ingredient, numerous studies have demonstrated that resveratrol possesses a very high antioxidant potential. Resveratrol also exhibit antitumor activity, and is considered a potential candidate for prevention and treatment of several types of cancer. Indeed, resveratrol anticancer properties have been confirmed by many in vitro and in vivo studies, which shows that resveratrol is able to inhibit all carcinogenesis stages (e.g., initiation, promotion and progression). Even more, other bioactive effects, namely as anti-inflammatory, anticarcinogenic, cardioprotective, vasorelaxant, phytoestrogenic and neuroprotective have also been reported. Nonetheless, resveratrol application is still being a major challenge for pharmaceutical industry, due to its poor solubility and bioavailability, as well as adverse effects. In this sense, this review summarized current data on resveratrol pharmacological effects. Keywords: resveratrol, physiological effects, pharmacological activity, antioxidant, anticancer, antimicrobial 1. INTRODUCTION Among many phytochemicals, phytoestrogens have been reported to contain several bioactive molecules, mostly found in soy, vegetables and fruits. These compounds can be classified into four main groups, such as isoflavonoids, flavonoids, stilbenes and lignans. From them, stilbenes, in particular trans-resveratrol and its glucoside, are widely reported to be beneficial to human health, having even shown to possess antioxidant, anticarcinogenic, antitumor and estrogenic/antiestrogenic activity [1]. Specifically, resveratrol is well known biologically active compound synthesized by plants undergoing infectious or ionizing radiation. Renaud and De Lorgeril were the first to relate wine polyphenols such as resveratrol, to the potential health benefits attributed to regular and moderate wine consumption (the so called “French Paradox”) [2]. Resveratrol has since received an increasing scientific attention, leading to investigation on its biological activity, and to numerous publications [3]. Resveratrol was first isolated from white hellebore (Veratrum grandiflorum O. Loes) roots in 1940, then from Polygonum cuspidatum roots in 1963, a plant used in traditional Chinese and Japanese Medicine as anti-inflammatory and anti-platelet agent. This natural polyphenol has been detected in more than 70 plant species, and is also found in discrete amounts in red wines and various human foods. High concentrations are present in grapes, possibly because of Vitis vinifera response to fungal infection. In plants, resveratrol acts as a phytoalexin that is synthesized in response to mechanical injury, UV irradiation and fungal attacks. For industrial purposes, resveratrol is generally obtained by chemical or biotechnological synthesis from yeasts Saccharomyces cerevisiae [4,5,6,7,8]. As of today, 92 new resveratrol compounds, including 39 dimers, 23 trimers, 13 tetramers, 6 resveratrol monomers, 6 hexamers, 4 pentamers, and 1 octamer have been reported from the Dipterocarpaceae, Paeoniaceae, Vitaceae, Leguminosae, Gnetaceae, Cyperaceae, Polygonaceae Gramineae, and Poaceae families [9]. Among these families, Dipterocarpaceae, containing 50 resveratrol’s, accounts for the majority, being involved 7 Dipterocarpaceae genera, including Vatica, Vateria, Shorea, Hopea, Neobalanocarpus, Dipterocarpus and Dryobalanops [9]. Currently, resveratrol is sold as a nutritional supplement with a wide range of pharmacological effects, including cellular defensive action against oxidative stress [10,11,12]. In this sense, the present review summarizes resveratrol’ beneficial health effects, including anticancer, antimicrobial, neuroprotective, antiaging, anti-inflammatory, cardioprotective and blood-sugar lowering properties, as also life-prolonging effects. 2. CHEMISTRY OF RESVERATROL Resveratrol is a stilbenoid polyphenol, possessing two phenol rings linked to each other by an ethylene bridge. The chemical structure of resveratrol (trans-3,5,4′-trihydroxystilbene) is identified in two isomeric forms, cis- and trans-resveratrol (Figure 1). trans form is dominant in terms of its prevalence and different biological activities are attributed, namely in inducing cellular responses such as cell cycle arrest, differentiation, apoptosis, and to enhance cancer cells anti-proliferation [13,14,15]. [Figure: Resveratrol chemical structure (cis and trans forms).] Formal chemical name (IUPAC name) of resveratrol is E-5-(4-hydroxystyryl)benzene-1,3-diol. Various aspects on resveratrol chemistry are currently being studied. It exists as two geometric isomers: cis-(Z) and trans-(E). trans form can undergo to cis form isomerization when exposed to UV irradiation. trans-resveratrol powder was found to be stable under “accelerated stability” conditions of 75% humidity and 40 °C in the presence of air. The low resveratrol bioavailability was encumbered its therapeutic application. Therefore, modification of resveratrol structure has received special attention from researchers and many resveratrol derivatives have been synthesized such as methoxylated, hydroxylated and halogenated derivatives, all of them exhibiting favorable therapeutic potential [3,16,17]. Resveratrol is present in dietary products as glycosylated forms, known as piceid. Though, plants and pathogens, and even human digestive tract possess enzymes able to triggers polyphenols oxidation (and subsequent inactivation), the glycosylation prevents enzymatic oxidation of resveratrol, thereby preserving its biological effects and increasing its overall stability and bioavailability [18]. Furthermore, since intestinal cells can absorb only resveratrol aglycone form, absorption process requires glycosidases. Therefore, the relative aglycone and glycosylated resveratrol amounts in foods and beverages may modulate its absorption rate [19]. Three glycosylated resveratrol analogues, piceid, piceatannol glucoside, and resveratroloside isolated from the invasive plant species Polygonum cuspidatum [19] were identified as the major antibacterial compounds [20]. Glycosylated resveratrol analogues have comparable biological effects after transepitelial passage, as they can be hydrolyzed into deglycosylated forms, resveratrol in the intestine [21]. However, in vitro studies have shown that the glycosylated analogues even show more powerful bioactivities. For example, resveratrol and piceid have similar antioxidant capacity, but piceid appears to be more efficacious than resveratrol due to its reaction with its radical form [22,23]. Indeed, resveratrol-glycoside was more effective than resveratrol against hepatitis B virus [24,25]. Piceatannol, with one more hydroxyl group, was already reported as having stronger anti-inflammatory, immunomodulatory, anti-proliferative, anti-leishmanial, anti-leukemic, and protein-tyrosine kinase inhibitory effects [19]. Pterostilbene, a natural methoxylated resveratrol analogue, was first isolated from Pterocarpus santalinus (red sandalwood), a plant used in traditional medicine for diabetes treatment [26]. This Pterocarpus marsupium active constituent is mainly found in blueberries, grapes, and several plant woods. [26,27]. Pterostilbene has a similar structure to resveratrol except that in A ring 3 and 5 position was replaced by a methoxyl group [26]. This compound pro-lipophilicity, greater than that of resveratrol, increases its bioavailability [28,29,30] resulting in stronger bioactivities, including anticancer, anti-lipidemic, antidiabetic, and cardioprotective effects than those of resveratrol [26,31,32]. In the same line, resveratrol nanoformulation have been conceived as a promising approach for biological function retaining, where polycaprolactone form the hydrophobic core, whereas polyethylene glycol form the hydrophilic shell of the encapsulated resveratrol micelles [33,34]. Solid lipid nanoparticles and nanostructured lipid carriers are two unique resveratrol nanodelivery systems that were developed to enhance resveratrol’ oral bioavailability for nutraceutical purposes [35]. Indeed, resveratrol nanoparticles led to an improvement in its solubility and enhances its antioxidant potential than free form [35,36]. For example, resveratrol nanoformulation exhibited an in vivo absorption raise, length of action extension and bioavailability improvement by 3.516 times more, when compared with raw form [37]. In addition, the hydrophobic nature of resveratrol considerably contributes to its limited bioavailability, which results from

Read the complete text